ES2046083B1 - Procedimiento para preparar composiciones de liberacion prolongada. - Google Patents

Procedimiento para preparar composiciones de liberacion prolongada.

Info

Publication number
ES2046083B1
ES2046083B1 ES09101785A ES9101785A ES2046083B1 ES 2046083 B1 ES2046083 B1 ES 2046083B1 ES 09101785 A ES09101785 A ES 09101785A ES 9101785 A ES9101785 A ES 9101785A ES 2046083 B1 ES2046083 B1 ES 2046083B1
Authority
ES
Spain
Prior art keywords
procedure
prolonged release
release compositions
preparing
active ingredients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES09101785A
Other languages
English (en)
Spanish (es)
Other versions
ES2046083A1 (es
Inventor
Jean-Marc Ruiz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Pharma SAS
Original Assignee
Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS filed Critical Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Publication of ES2046083A1 publication Critical patent/ES2046083A1/es
Application granted granted Critical
Publication of ES2046083B1 publication Critical patent/ES2046083B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Biological Depolymerization Polymers (AREA)
  • Glanulating (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES09101785A 1990-08-01 1991-07-30 Procedimiento para preparar composiciones de liberacion prolongada. Expired - Fee Related ES2046083B1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909016885A GB9016885D0 (en) 1990-08-01 1990-08-01 Sustained release pharmaceutical compositions

Publications (2)

Publication Number Publication Date
ES2046083A1 ES2046083A1 (es) 1994-01-16
ES2046083B1 true ES2046083B1 (es) 1994-08-01

Family

ID=10679993

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09101785A Expired - Fee Related ES2046083B1 (es) 1990-08-01 1991-07-30 Procedimiento para preparar composiciones de liberacion prolongada.

Country Status (30)

Country Link
US (1) US5213812A (OSRAM)
JP (1) JP2818704B2 (OSRAM)
KR (1) KR920003962A (OSRAM)
AT (1) AT396425B (OSRAM)
AU (2) AU649696B2 (OSRAM)
BE (1) BE1004772A3 (OSRAM)
CA (1) CA2048270C (OSRAM)
CH (1) CH682715A5 (OSRAM)
DE (1) DE4125542A1 (OSRAM)
DK (1) DK175756B1 (OSRAM)
ES (1) ES2046083B1 (OSRAM)
FI (1) FI104149B1 (OSRAM)
FR (1) FR2665360B1 (OSRAM)
GB (1) GB9016885D0 (OSRAM)
GR (1) GR1001512B (OSRAM)
HK (1) HK33294A (OSRAM)
IE (1) IE65124B1 (OSRAM)
IN (1) IN178446B (OSRAM)
IT (1) IT1251788B (OSRAM)
LU (1) LU87982A1 (OSRAM)
MA (1) MA22245A1 (OSRAM)
MY (1) MY107500A (OSRAM)
NL (1) NL194637C (OSRAM)
NO (1) NO300158B1 (OSRAM)
NZ (1) NZ238981A (OSRAM)
OA (1) OA09387A (OSRAM)
PT (1) PT98497B (OSRAM)
SE (1) SE505734C2 (OSRAM)
TN (1) TNSN91067A1 (OSRAM)
ZA (1) ZA915565B (OSRAM)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US5569467A (en) * 1993-05-15 1996-10-29 Societe De Conseils De Recherches Et D'applications (S.C.R.A.S.) Process for the preparation of microballs and microballs thus obtained
GB9310030D0 (en) * 1993-05-15 1993-06-30 Scras Dry processed particles and process for the preparation of the same
JP2930421B2 (ja) * 1994-02-28 1999-08-03 メディノヴァ メディカル コンサルティング ゲゼルシャフト ミット ベシュレンクテル ハフツング 薬剤組成物、その製造方法及びその使用方法
US5980945A (en) * 1996-01-16 1999-11-09 Societe De Conseils De Recherches Et D'applications Scientifique S.A. Sustained release drug formulations
DE19604744A1 (de) 1996-02-09 1997-08-14 Henkel Kgaa Technische Di-/Triglyceridgemische
DE19617137C1 (de) * 1996-04-29 1997-02-27 Henkel Kgaa Verwendung von Copolymerestern für die Herstellung von Mikrosphären
AU4571097A (en) * 1996-10-09 1998-05-05 Takeda Chemical Industries Ltd. A method for producing a microparticle
AR012448A1 (es) * 1997-04-18 2000-10-18 Ipsen Pharma Biotech Composicion en forma de microcapsulas o de implantes que comprende un excipiente biodegradable, polimero o co-polimero, o una mezcla de talesexcipientes, y una sustancia activa o una mezcla de sustancias activas, procedimiento para la preparacion de una sustancia soluble en agua de elevada
EP1079967A4 (en) 1998-04-13 2003-07-23 Luminex Corp LIQUID MARKING USING FLUORESCENT MICROPARTICLES
AU770673B2 (en) * 1998-12-16 2004-02-26 Aventisub Ii Inc. Biodegradable polymer encapsulated serotonin receptor antagonist and method for preparing the same
AU5644400A (en) * 1999-09-24 2001-03-29 Rohm And Haas Company Pellet compositions
US6458387B1 (en) * 1999-10-18 2002-10-01 Epic Therapeutics, Inc. Sustained release microspheres
ES2326209T3 (es) 2000-10-27 2009-10-05 Baxter Healthcare S.A. Produccion de microesferas.
PT1418890E (pt) * 2001-08-16 2008-06-09 Baxter Int Formulações de micropartículas à base de propulsor
US20080026068A1 (en) * 2001-08-16 2008-01-31 Baxter Healthcare S.A. Pulmonary delivery of spherical insulin microparticles
US20040166077A1 (en) * 2002-12-04 2004-08-26 L'oreal Process for treating keratin materials with aromatic active principles
FR2848113B1 (fr) * 2002-12-04 2005-02-25 Oreal Stabilisation de principes actifs aromatiques par des polymeres aromatiques
WO2005035088A2 (en) * 2003-07-18 2005-04-21 Baxter International, Inc. Method for preparing small spherical by controlled phase separation
US20050142205A1 (en) * 2003-07-18 2005-06-30 Julia Rashba-Step Methods for encapsulating small spherical particles prepared by controlled phase separation
US20070092452A1 (en) * 2003-07-18 2007-04-26 Julia Rashba-Step Methods for fabrication, uses, compositions of inhalable spherical particles
EP1646354A4 (en) * 2003-07-22 2010-03-17 Baxter Int SMALL SPHERICAL PARTICLES OF LOW MOLECULAR WEIGHT MOLECULES AND PROCESSES FOR THEIR PREPARATION AND USE
US20060135277A1 (en) * 2003-09-10 2006-06-22 Marnocha Bendict F Golf club and practice arrangement
FR2865938B1 (fr) * 2004-02-05 2006-06-02 Sod Conseils Rech Applic Formulation retard solide comprenant de l'acetate de triptoreline
US8728525B2 (en) * 2004-05-12 2014-05-20 Baxter International Inc. Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
AU2005244840C1 (en) * 2004-05-12 2012-05-10 Baxter Healthcare S.A. Microspheres comprising protein and showing injectability at high concentrations of said agent
EP2335689A1 (en) 2004-05-12 2011-06-22 Baxter International Inc. Method of manufacturing nucleic acid micropheres
US7884085B2 (en) * 2004-05-12 2011-02-08 Baxter International Inc. Delivery of AS-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes
KR20070042176A (ko) * 2004-07-13 2007-04-20 알타이어나노 인코포레이티드 약물 전용의 방지를 위한 세라믹 구조체
CN101010051A (zh) * 2004-07-13 2007-08-01 爱尔达纳米公司 用于控释药物的陶瓷结构
US20070243234A1 (en) * 2004-10-29 2007-10-18 Peter Gabriele Microscopic Tagging System for Security Identification
US20060260777A1 (en) * 2005-04-27 2006-11-23 Julia Rashba-Step Surface-modified microparticles and methods of forming and using the same
EP1928814A2 (en) * 2005-08-23 2008-06-11 Altairnano, Inc HIGHLY PHOTOCATALYTIC PHOSPHORUS-DOPED ANATASE-TiO2 COMPOSITION AND RELATED MANUFACTURING METHODS
WO2007103829A1 (en) * 2006-03-02 2007-09-13 Altairnano, Inc. Method for production of metal oxide coatings
US20080038482A1 (en) * 2006-03-02 2008-02-14 Fred Ratel Method for Low Temperature Production of Nano-Structured Iron Oxide Coatings
US20080020175A1 (en) * 2006-03-02 2008-01-24 Fred Ratel Nanostructured Indium-Doped Iron Oxide
US20070281031A1 (en) * 2006-06-01 2007-12-06 Guohan Yang Microparticles and methods for production thereof
MX2009001226A (es) * 2006-08-04 2009-03-20 Baxter Int Composicion basada en microesferas para prevenir y/o revertir la diabetes autoinmune de nuevo inicio.
EP2068845A2 (en) * 2006-10-06 2009-06-17 Baxter International Inc. Microencapsules containing surface-modified microparticles and methods of forming and using the same
CA2702340C (en) 2006-10-12 2014-12-16 The University Of Queensland Compositions and methods for modulating immune responses
US20090169628A1 (en) * 2006-10-17 2009-07-02 Armark Authentication Technologies, Llc Article and method for focused delivery of therapeutic and/or diagnostic materials
US20080254258A1 (en) * 2007-04-12 2008-10-16 Altairnano, Inc. Teflon® replacements and related production methods
CN101686939B (zh) * 2007-04-17 2013-03-27 巴克斯特国际公司 用于肺部投送的核酸微粒
US9782300B2 (en) 2008-02-01 2017-10-10 Kci Licensing, Inc. Fiber-microsphere bioresorbable composite scaffold for wound healing
PL2281042T3 (pl) 2008-04-18 2016-01-29 Baxter Int Kompozycja na bazie mikrosfer do zapobiegania i/lub cofania nowego przypadku cukrzycy autoimmunologicznej
US8323615B2 (en) * 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing multi-phasic dispersions
US20100047292A1 (en) * 2008-08-20 2010-02-25 Baxter International Inc. Methods of processing microparticles and compositions produced thereby
US8367427B2 (en) * 2008-08-20 2013-02-05 Baxter International Inc. Methods of processing compositions containing microparticles
US8323685B2 (en) * 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing compositions containing microparticles
US20100078848A1 (en) * 2008-09-29 2010-04-01 Armark Authentication Technologies, Llc Spinneret and method of spinning fiber
US20100291214A1 (en) * 2008-12-23 2010-11-18 Armark Authentication Technologies, Llc Three-dimensional microfiber extrudate structure and process for forming three-dimensional microfiber extrudate structure
WO2010132763A1 (en) * 2009-05-15 2010-11-18 Armark Authentication Technologies, Llc Fiber having non-uniform composition and method for making same
CA2762647A1 (en) * 2009-05-27 2010-12-02 Selecta Biosciences, Inc. Nanocarriers possessing components with different rates of release
US20110076771A1 (en) * 2009-09-25 2011-03-31 Armark Authentication Technologies, Llc Tissue fiber scaffold and method for making
US20110293701A1 (en) 2010-05-26 2011-12-01 Selecta Biosciences, Inc. Multivalent synthetic nanocarrier vaccines
EP2399931A1 (fr) * 2010-06-22 2011-12-28 Ipsen Pharma S.A.S. Nouveaux composés octapeptidiques et leur utilisation thérapeutique
DK2635596T3 (da) 2010-11-01 2019-11-25 Univ Sydney Technology Immun-moduleringsmidler og anvendelser dertil
US20130028857A1 (en) 2011-07-29 2013-01-31 Selecta Biosciences, Inc. Synthetic nanocarriers comprising polymers comprising multiple immunomodulatory agents
DK3149049T3 (da) 2014-05-27 2023-01-23 Univ Queensland Il-22 til anvendelse til behandling af stofskiftesygdomme
FR3067226B1 (fr) * 2017-06-13 2021-10-08 Rossignol Lange Element de chaussure de ski

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3567650A (en) * 1969-02-14 1971-03-02 Ncr Co Method of making microscopic capsules
US4010125A (en) * 1975-06-12 1977-03-01 Schally Andrew Victor [D-Trp6 ]-LH-RH and intermediates therefor
US4675189A (en) * 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
IN167096B (OSRAM) * 1985-04-04 1990-09-01 Akzo Nv
US4666705A (en) * 1985-06-03 1987-05-19 E. R. Squibb & Sons, Inc. Controlled release formulation
GB8628728D0 (en) * 1986-12-02 1987-01-07 Euro Celtique Sa Spheroids
GB8705083D0 (en) * 1987-03-04 1987-04-08 Euro Celtique Sa Spheroids
AU4369589A (en) * 1988-10-27 1990-05-03 Abbott Laboratories Controlled-release delivery device, method for producing device, and method of using device

Also Published As

Publication number Publication date
OA09387A (fr) 1992-09-15
FI913646L (fi) 1992-02-02
FI104149B (fi) 1999-11-30
FR2665360B1 (fr) 1995-02-10
AU666808B2 (en) 1996-02-22
CA2048270A1 (en) 1992-02-02
ES2046083A1 (es) 1994-01-16
SE9102249L (sv) 1992-02-02
US5213812A (en) 1993-05-25
LU87982A1 (fr) 1992-04-15
FI104149B1 (fi) 1999-11-30
AU8146691A (en) 1992-02-06
PT98497A (pt) 1992-06-30
NL9101306A (nl) 1992-03-02
IT1251788B (it) 1995-05-26
SE9102249D0 (sv) 1991-07-26
DK141891D0 (da) 1991-07-31
DK141891A (da) 1992-02-02
AU649696B2 (en) 1994-06-02
JPH05178740A (ja) 1993-07-20
AT396425B (de) 1993-09-27
DE4125542A1 (de) 1992-02-06
TNSN91067A1 (fr) 1992-10-25
ITMI911953A0 (it) 1991-07-15
DK175756B1 (da) 2005-02-14
FR2665360A1 (fr) 1992-02-07
KR920003962A (ko) 1992-03-27
JP2818704B2 (ja) 1998-10-30
GB9016885D0 (en) 1990-09-12
PT98497B (pt) 1997-10-31
GR910100330A (en) 1992-08-31
ITMI911953A1 (it) 1993-01-15
HK33294A (en) 1994-04-22
ZA915565B (en) 1992-04-29
IE65124B1 (en) 1995-10-04
CA2048270C (en) 1997-02-25
ATA152591A (de) 1993-01-15
IE912700A1 (en) 1992-02-12
GR1001512B (el) 1994-02-28
NO912986D0 (no) 1991-07-31
FI913646A0 (fi) 1991-07-31
IN178446B (OSRAM) 1997-05-03
MY107500A (en) 1995-12-30
AU5939394A (en) 1994-06-02
NL194637C (nl) 2002-10-04
CH682715A5 (fr) 1993-11-15
NO300158B1 (no) 1997-04-21
NL194637B (nl) 2002-06-03
NO912986L (no) 1992-02-03
SE505734C2 (sv) 1997-10-06
NZ238981A (en) 1992-11-25
MA22245A1 (fr) 1992-04-01
BE1004772A3 (fr) 1993-01-26

Similar Documents

Publication Publication Date Title
ES2046083B1 (es) Procedimiento para preparar composiciones de liberacion prolongada.
HRP20010463B1 (hr) Smjesa s kontroliranim otpuštanjem koja sadrži galantamin
AU7315301A (en) Compounds and compositions for delivering active agents
ES2031096T3 (es) Una composicion de implante mejorada a base de estradiol y metodo para su preparacion.
SE9003665D0 (sv) Morphine prodrugs
IL115721A0 (en) Methods and compositions for the modulation of cell proliferation and wound healing
MXPA01008611A (es) Compuestos y composiciones para suministrar agentes activos.
BR0009893A (pt) Composição de cuidado com a pele; e uso de uma composição de cuidado com a pele
DK0589893T3 (da) Anvendelse af et bakteriocin som antimikrobielt middel til fremstilling af et lægemiddel til behandl ing af maveforstyrrelser forbundet med helicobacter pylori
ATE286725T1 (de) Neue oral anzuwendende arzneizubereitungen für rivastigmine mit kontrollierter wirkstoffabgabe
DE60129849D1 (de) Bioadhäsiver schaumstoffilm mit hinhaltender wirkstoffreigabe
ATE324907T1 (de) Verbindung und arzneizusammensetzung zur verabreichung von wirkstoffen
MXPA02008117A (es) Particulas de ceramica de liberacion controlada composiciones de estas, procesos de su preparacion y metodos de uso.
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
HUP9702457A3 (en) Synergistic herbicidal compositions containing glufosinate and nitrodiphenyl ether derivatives as active ingredients and use thereof
DE60040753D1 (de) Therapeutische verwendungen von steroiden bei blutzellmangelzustaenden
DK0975334T3 (da) Biologisk nedbrydelige mikropartikler til langvarig frigivelse af terapeutiske midler
DK1121127T3 (da) Orale farmaceutiske sammensætninger, som indeholder buprenorphin
WO2002015959A3 (en) Compounds and compositions for delivering active agents
AU8916198A (en) Composition, device and method of using
ATE281830T1 (de) Geschmacksneutrale pharmazeutische zusammensetzungen
DE69727385D1 (de) Benzophenanthridinalkaloid-enthaltende pestizide
NO941097D0 (no) Hudregenererende kosmetisk preparat
DK0469440T3 (da) Faste orale applikationsformer, der som aktivt stof indeholder ifosamid
MX9301057A (es) Nuevos esteres de oxima azoica, a procedimientos para su preparacion, a su uso como fungicidas y a composiciones que los comprenden.

Legal Events

Date Code Title Description
FD2A Announcement of lapse in spain

Effective date: 20110819